 effect rescu dose synthet surfact mortal rate surviv bronchopulmonari dysplasia infant respiratori distress syndrom american exosurf neonat studi group multicent double-blind placebo-control rescu trial american hospit ml/kg dose synthet surfact exosurf neonat air infant gm respiratori distress syndrom arterial/alveolar oxygen pressur ratio first dose hour age second dose hour infant ventilatori support infant entri birth weight gender infant synthet surfact improv alveolar-arteri oxygen pressur gradient arterial/alveolar oxygen pressur ratio oxygen ventil need day age appar death respiratori distress syndrom third overal neonat mortal rate half signific reduct incid bronchopulmonari dysplasia hypothesi day bronchopulmonari dysplasia rescu dose synthet surfact true improv patient addit incid pneumothorax third incid pulmonari interstiti emphysema half side effect increas incid apnea find rescu use synthet surfact morbid mortal rate prematur infant respiratori distress syndrom